Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
DNLI
DNLI News & Events
-
Add to Watchlist
Trade DNLI
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
DNLI News
Denali Therapeutics Reports Q4 Results and Stock Offering
1d ago
seekingalpha
Shifting Trends in Biotechnology Mergers and Acquisitions
Feb 19 2026
Globenewswire
REGENXBIO Faces FDA Challenges for Gene Therapy Approval
Feb 10 2026
Newsfilter
REGENXBIO's RGX-121 BLA Accepted by FDA Under Accelerated Approval Pathway
Feb 10 2026
Benzinga
Denali Therapeutics Advances in Hunter Syndrome Treatment
Feb 05 2026
Newsfilter
Denali Therapeutics Presents Clinical Data at WORLDSymposium 2026
Jan 29 2026
Yahoo Finance
Denali Therapeutics (DNLI) Offers Covered Call with 2.60% Potential Return
Jan 20 2026
NASDAQ.COM
Denali Therapeutics Advances Tividenofusp Alfa with FDA Priority Review for Hunter Syndrome
Dec 30 2025
Globenewswire
Show More News
DNLI Events
No data
DNLI Monitor News
Denali Therapeutics Inc Stock Declines Amid Market Weakness
Dec 10 2025
DNLI Earnings Analysis
No Data
People Also Watch
